ArticleTranslational andrology and urology2021

Efficacy and safety of immunological checkpoint inhibitors combined with anti-angiogenic drugs in first-line treatment of metastatic renal cell carcinoma: a systematic review and meta-analysis.

Yingwei Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.